+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neuromonitoring Devices Market By Product: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 175 Pages
  • June 2022
  • Region: Global
  • Allied Market Research
  • ID: 5671087
The global neuromonitoring devices market was valued at $5,593.1 million in 2021 and is projected to reach $10,276 million by 2030, growing at a CAGR of 7.24% from 2022 to 2030.
Rising demand for non-invasive and minimally invasive medical devices is expected to drive the global nuromonitoring devices market. Because it includes intervention with sensitive brain tissue, intrusive tracking is a complex, distressing, and dangerous procedure. As a result, both patients and doctors prefer the use of non-invasive or non-invasive nuromonitoring devices. Because of their advantages, non-invasive ICP monitoring systems, computed tomography devices, tympanic displacement procedures, nervous system sheath diameter, chest x ray, and fundoscopy have seen a rapid upsurge, compelling market participants to grow and commercialize such products. All such factors are expected to drive the neuromonitoring devices market during the forecast period.

The market for neuromonitoring devices is likely to face some major hindrance due to high cost of the devices. Neuromonitoring devices are highly expensive due to the use of many costly equipment such as advanced sensors, electrodes, and wirings used for their construction. Also, less availability of skilled personnel to operate such devices is further anticipated to impede the market growth.

To meet the rising demand for advanced neuromonitoring devices, key market players are constantly innovating their portfolio of neuromonitoring devices. For this reason, companies have begun to invest heavily in advancing their research and development activities and developing new and advanced product lines.

The global neuromonitoring devices market is segmented on the basis of product and region. By product, the market is classified into intracranial pressure monitoring, cerebral oximeter, near infrared spectroscopy, speckle imaging, doppler ultrasound, EEG, fetal/neonatal neuromonitoring devices, micro ultrasound, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this report include GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated., Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.

Key Market Segments

By Product

  • Intracranial Pressure Monitoring
  • Cerebral Oximeter
  • Near Infrared Spectroscopy
  • Speckle Imaging
  • Doppler Ultrasound
  • EEG
  • Fetal/Neonatal Neuro-Monitoring Devices
  • Micro Ultrasound
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest Of Asia Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Koninklijke Philips N.V.
  • Nihon Kohden Corporation
  • Natus Medical Incorporated
  • Medtronic Plc
  • GE Healthcare
  • Nuvasive, Inc.
  • Advanced Brain Monitoring, Inc.
  • Intranerve Neuroscience Holdings, LLC
  • RIMED Ltd.
  • SpecialtyCare
Frequently Asked Questions about the Global Neuromonitoring Devices Market

What is the estimated value of the Global Neuromonitoring Devices Market?

The Global Neuromonitoring Devices Market was estimated to be valued at $5593.1 million in 2021.

What is the growth rate of the Global Neuromonitoring Devices Market?

The growth rate of the Global Neuromonitoring Devices Market is 7.0%, with an estimated value of $10276 million by 2030.

What is the forecasted size of the Global Neuromonitoring Devices Market?

The Global Neuromonitoring Devices Market is estimated to be worth $10276 million by 2030.

Who are the key companies in the Global Neuromonitoring Devices Market?

Key companies in the Global Neuromonitoring Devices Market include Koninklijke Philips N.V., Nihon Kohden Corporation, Natus Medical Incorporated, Medtronic plc, Ge Healthcare, Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, LLC, Rimed Ltd. and Specialtycare.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Regulatory Guidelines
3.8.Value Chain Analysis
3.9.Market Share Analysis
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: NEUROMONITORING DEVICES MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Intracranial Pressure Monitoring
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Cerebral Oximeter
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Near Infrared Spectroscopy
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Speckle Imaging
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Doppler Ultrasound
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 EEG
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
4.8 Fetal/Neonatal Neuro-Monitoring Devices
4.8.1 Key market trends, growth factors and opportunities
4.8.2 Market size and forecast, by region
4.8.3 Market analysis by country
4.9 Micro Ultrasound
4.9.1 Key market trends, growth factors and opportunities
4.9.2 Market size and forecast, by region
4.9.3 Market analysis by country
5.0 Others
5.0.1 Key market trends, growth factors and opportunities
5.0.2 Market size and forecast, by region
5.0.3 Market analysis by country
CHAPTER 5: NEUROMONITORING DEVICES MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Product
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Product
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Product
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Product
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Product
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Product
5.3.3.2 United Kingdom
5.3.3.2.1 Market size and forecast, by Product
5.3.3.3 France
5.3.3.3.1 Market size and forecast, by Product
5.3.3.4 Spain
5.3.3.4.1 Market size and forecast, by Product
5.3.3.5 Italy
5.3.3.5.1 Market size and forecast, by Product
5.3.3.6 Rest of Europe
5.3.3.6.1 Market size and forecast, by Product
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Product
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 China
5.4.3.1.1 Market size and forecast, by Product
5.4.3.2 Japan
5.4.3.2.1 Market size and forecast, by Product
5.4.3.3 India
5.4.3.3.1 Market size and forecast, by Product
5.4.3.4 South Korea
5.4.3.4.1 Market size and forecast, by Product
5.4.3.5 Australia
5.4.3.5.1 Market size and forecast, by Product
5.4.3.6 Rest Of Asia Pacific
5.4.3.6.1 Market size and forecast, by Product
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Product
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Brazil
5.5.3.1.1 Market size and forecast, by Product
5.5.3.2 Saudi Arabia
5.5.3.2.1 Market size and forecast, by Product
5.5.3.3 UAE
5.5.3.3.1 Market size and forecast, by Product
5.5.3.4 South Africa
5.5.3.4.1 Market size and forecast, by Product
5.5.3.5 Rest of LAMEA
5.5.3.5.1 Market size and forecast, by Product
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 Nihon Kohden Corporation
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 Natus Medical Incorporated
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 Medtronic Plc
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 GE Healthcare
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 Nuvasive, Inc.
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 Advanced Brain Monitoring, Inc.
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 Intranerve Neuroscience Holdings, LLC
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 RIMED Ltd.
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 SpecialtyCare
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments
List of Tables
Table 1. Global Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 2. Home Decontamination Services Market Size, for Biohazard Cleaning, by Region, 2021-2031 ($Million)
Table 3. Home Decontamination Services Market for Biohazard Cleaning by Country, 2021-2031 ($Million)
Table 4. Home Decontamination Services Market Size, for Infection Prevention and Control, by Region, 2021-2031 ($Million)
Table 5. Home Decontamination Services Market for Infection Prevention and Control by Country, 2021-2031 ($Million)
Table 6. Home Decontamination Services Market Size, for Others, by Region, 2021-2031 ($Million)
Table 7. Home Decontamination Services Market for Others by Country, 2021-2031 ($Million)
Table 8. Global Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 9. Home Decontamination Services Market Size, for Apartments, by Region, 2021-2031 ($Million)
Table 10. Home Decontamination Services Market for Apartments by Country, 2021-2031 ($Million)
Table 11. Home Decontamination Services Market Size, for Independent House, by Region, 2021-2031 ($Million)
Table 12. Home Decontamination Services Market for Independent House by Country, 2021-2031 ($Million)
Table 13. Home Decontamination Services Market Size, for Vilas, by Region, 2021-2031 ($Million)
Table 14. Home Decontamination Services Market for Vilas by Country, 2021-2031 ($Million)
Table 15. Home Decontamination Services Market, by Region, 2021-2031 ($Million)
Table 16. North America Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 17. North America Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 18. North America Home Decontamination Services Market, by Country, 2021-2031 ($Million)
Table 19. U.S. Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 20. U.S. Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 21. Canada Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 22. Canada Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 23. Mexico Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 24. Mexico Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 25. Europe Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 26. Europe Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 27. Europe Home Decontamination Services Market, by Country, 2021-2031 ($Million)
Table 28. Germany Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 29. Germany Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 30. U.K. Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 31. U.K. Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 32. France Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 33. France Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 34. Italy Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 35. Italy Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 36. Spain Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 37. Spain Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 38. Rest of Europe Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 39. Rest of Europe Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 40. Asia-Pacific Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 41. Asia-Pacific Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 42. Asia-Pacific Home Decontamination Services Market, by Country, 2021-2031 ($Million)
Table 43. China Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 44. China Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 45. Japan Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 46. Japan Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 47. India Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 48. India Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 49. Australia Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 50. Australia Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 51. South Korea Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 52. South Korea Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 53. Rest of Asia-Pacific Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 54. Rest of Asia-Pacific Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 55. LAMEA Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 56. LAMEA Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 57. LAMEA Home Decontamination Services Market, by Country, 2021-2031 ($Million)
Table 58. Brazil Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 59. Brazil Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 60. Argentina Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 61. Argentina Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 62. UAE Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 63. UAE Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 64. Saudi Arabia Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 65. Saudi Arabia Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 66. South Africa Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 67. South Africa Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 68. Rest of LAMEA Home Decontamination Services Market, by Type, 2021-2031 ($Million)
Table 69. Rest of LAMEA Home Decontamination Services Market, by End-user, 2021-2031 ($Million)
Table 70. Bio Decontamination Ltd.: Company Snapshot
Table 71. Bio Decontamination Ltd.: Operating Segments
Table 72. Bio Decontamination Ltd.: Product Portfolio
Table 73. Bio Decontamination Ltd.: Net Sales
Table 74. Bio Decontamination Ltd.: Key Stratergies
Table 75. Enviroserve: Company Snapshot
Table 76. Enviroserve: Operating Segments
Table 77. Enviroserve: Product Portfolio
Table 78. Enviroserve: Net Sales
Table 79. Enviroserve: Key Stratergies
Table 80. Everwell Clean.: Company Snapshot
Table 81. Everwell Clean.: Operating Segments
Table 82. Everwell Clean.: Product Portfolio
Table 83. Everwell Clean.: Net Sales
Table 84. Everwell Clean.: Key Stratergies
Table 85. Jp Mchale Pest Management, LLC: Company Snapshot
Table 86. Jp Mchale Pest Management, LLC: Operating Segments
Table 87. Jp Mchale Pest Management, LLC: Product Portfolio
Table 88. Jp Mchale Pest Management, LLC: Net Sales
Table 89. Jp Mchale Pest Management, LLC: Key Stratergies
Table 90. Nyc Steam Cleaning: Company Snapshot
Table 91. Nyc Steam Cleaning: Operating Segments
Table 92. Nyc Steam Cleaning: Product Portfolio
Table 93. Nyc Steam Cleaning: Net Sales
Table 94. Nyc Steam Cleaning: Key Stratergies
Table 95. Rentokil Pest Control: Company Snapshot
Table 96. Rentokil Pest Control: Operating Segments
Table 97. Rentokil Pest Control: Product Portfolio
Table 98. Rentokil Pest Control: Net Sales
Table 99. Rentokil Pest Control: Key Stratergies
Table 100. Shiny Carpet Cleaning: Company Snapshot
Table 101. Shiny Carpet Cleaning: Operating Segments
Table 102. Shiny Carpet Cleaning: Product Portfolio
Table 103. Shiny Carpet Cleaning: Net Sales
Table 104. Shiny Carpet Cleaning: Key Stratergies
Table 105. Stratus Building Solutions: Company Snapshot
Table 106. Stratus Building Solutions: Operating Segments
Table 107. Stratus Building Solutions: Product Portfolio
Table 108. Stratus Building Solutions: Net Sales
Table 109. Stratus Building Solutions: Key Stratergies
Table 110. The Ecosense Company: Company Snapshot
Table 111. The Ecosense Company: Operating Segments
Table 112. The Ecosense Company: Product Portfolio
Table 113. The Ecosense Company: Net Sales
Table 114. The Ecosense Company: Key Stratergies
Table 115. The Terminix International Company Limited: Company Snapshot
Table 116. The Terminix International Company Limited: Operating Segments
Table 117. The Terminix International Company Limited: Product Portfolio
Table 118. The Terminix International Company Limited: Net Sales
Table 119. The Terminix International Company Limited: Key Stratergies
List of Figures
Figure 1. Neuromonitoring Devices Market Segmentation
Figure 2. Neuromonitoring Devices Market,2021-2030
Figure 3. Neuromonitoring Devices Market,2021-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Neuromonitoring Devices Market:Drivers, Restraints and Opportunities
Figure 12. Regulatory Guidelines
Figure 13. Value Chain Analysis
Figure 14. Market Share Analysis
Figure 15. Key Regulation Analysis
Figure 16. Patent Analysis by Company
Figure 17. Patent Analysis by Country
Figure 18. Neuromonitoring Devices Market,By Product,2021(%)
Figure 19. Comparative Share Analysis of Intracranial Pressure Monitoring Neuromonitoring Devices Market,2021-2030(%)
Figure 20. Comparative Share Analysis of Cerebral Oximeter Neuromonitoring Devices Market,2021-2030(%)
Figure 21. Comparative Share Analysis of Near Infrared Spectroscopy Neuromonitoring Devices Market,2021-2030(%)
Figure 22. Comparative Share Analysis of Speckle Imaging Neuromonitoring Devices Market,2021-2030(%)
Figure 23. Comparative Share Analysis of Doppler Ultrasound Neuromonitoring Devices Market,2021-2030(%)
Figure 24. Comparative Share Analysis of EEG Neuromonitoring Devices Market,2021-2030(%)
Figure 25. Comparative Share Analysis of Fetal/Neonatal Neuro-Monitoring Devices Neuromonitoring Devices Market,2021-2030(%)
Figure 26. Comparative Share Analysis of Micro Ultrasound Neuromonitoring Devices Market,2021-2030(%)
Figure 27. Comparative Share Analysis of Others Neuromonitoring Devices Market,2021-2030(%)
Figure 28. Neuromonitoring Devices Market by Region,2021
Figure 29. U.S. Neuromonitoring Devices Market,2021-2030($Million)
Figure 30. Canada Neuromonitoring Devices Market,2021-2030($Million)
Figure 31. Mexico Neuromonitoring Devices Market,2021-2030($Million)
Figure 32. Germany Neuromonitoring Devices Market,2021-2030($Million)
Figure 33. United Kingdom Neuromonitoring Devices Market,2021-2030($Million)
Figure 34. France Neuromonitoring Devices Market,2021-2030($Million)
Figure 35. Spain Neuromonitoring Devices Market,2021-2030($Million)
Figure 36. Italy Neuromonitoring Devices Market,2021-2030($Million)
Figure 37. Rest of Europe Neuromonitoring Devices Market,2021-2030($Million)
Figure 38. China Neuromonitoring Devices Market,2021-2030($Million)
Figure 39. Japan Neuromonitoring Devices Market,2021-2030($Million)
Figure 40. India Neuromonitoring Devices Market,2021-2030($Million)
Figure 41. South Korea Neuromonitoring Devices Market,2021-2030($Million)
Figure 42. Australia Neuromonitoring Devices Market,2021-2030($Million)
Figure 43. Rest of Asia-Pacific Neuromonitoring Devices Market,2021-2030($Million)
Figure 44. Brazil Neuromonitoring Devices Market,2021-2030($Million)
Figure 45. Saudi Arabia Neuromonitoring Devices Market,2021-2030($Million)
Figure 46. Uae Neuromonitoring Devices Market,2021-2030($Million)
Figure 47. South Africa Neuromonitoring Devices Market,2021-2030($Million)
Figure 48. Rest of LAMEA Neuromonitoring Devices Market,2021-2030($Million)
Figure 49. Top Winning Strategies, by Year
Figure 50. Top Winning Strategies, by Development
Figure 51. Top Winning Strategies, by Company
Figure 52. Product Mapping of Top 10 Players
Figure 53. Competitive Dashboard
Figure 54. Competitive Heatmap of Top 10 Key Players
Figure 55. Koninklijke Philips N.V..: Net Sales ,($Million)
Figure 56. Nihon Kohden Corporation.: Net Sales ,($Million)
Figure 57. Natus Medical Incorporated.: Net Sales ,($Million)
Figure 58. Medtronic PLC.: Net Sales ,($Million)
Figure 59. GE Healthcare.: Net Sales ,($Million)
Figure 60. Nuvasive, Inc..: Net Sales ,($Million)
Figure 61. Advanced Brain Monitoring, Inc..: Net Sales ,($Million)
Figure 62. Intranerve Neuroscience Holdings, LLC.: Net Sales ,($Million)
Figure 63. Rimed Ltd..: Net Sales ,($Million)
Figure 64. Specialtycare.: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Neuromonitoring Devices Market," the neuromonitoring devices market was valued at $5.6 billion in 2021, and is estimated to reach $10.3 billion by 2030, growing at a CAGR of 7.24% from 2022 to 2030.

The high prevalence of neurological diseases such as brain tumours, epilepsy, and seizures among people, the global neuromonitoring devices market is expected to grow at a rapid pace. Hospitalizations and emergency department admissions have increased in recent years as disease rates have risen, increasing the demand for neuromonitoring devices. To provide advanced technological diagnosis to patients, healthcare professionals have chosen to use the latest technology in neuromonitoring devices, which has resulted in the neuromonitoring devices market experiencing significant growth. Aside from that, the preference of patients and healthcare providers for wearable neuromonitoring devices to avoid unnecessary hospital visits is expected to drive the market in the forecast time period.

Neuromonitoring devices are quite expensive and are only available to people who can afford them as a therapeutic option. This factor prevents the market from expanding. Furthermore, due to the high cost of the gadgets, few healthcare institutions in rural regions, such as tiny hospitals and clinics, can not afford to maintain these costly instruments for patient treatment. The high cost of neuromonitoring operations and equipment is a major impediment to the global neuromonitoring devices market growth, particularly in developing nations where reimbursement standards are lenient. Neuromonitoring systems are exceedingly intricate, and the treatments very expensive. A neuromonitor, for example, costs roughly $340-500, whereas dual computed tomography costs around $3,000-3,200. All of these factors are projected to hamper the neuromonitoring device market in the near future.

Spine surgery is one of the fastest-growing specialities in medical tourism, increased medical tourism is a key trend for neuromonitoring products and service providers. The use of neuromonitoring in medical tourism would enhance surgical outcomes all over the world. Patients who travel for medical treatment are typically consumers as well as decision-makers. As a consequence of the rising demand from medical tourism patients, the need for neuromonitoring equipment in hospitals may expand. Medical tourism would also increase awareness of the importance of neuromonitoring and how to use it during procedures. The aforementioned factors are projected to boost the global neuromonitoring devices market share over the forecast period.

The global neuromonitoring devices market is segmented on the basis of product, and region. By product, the market is classified into intracranial pressure monitoring, cerebral oximeter, near-infrared spectroscopy, speckle imaging, doppler ultrasound, EEG, fetal/neonatal neuromonitoring devices, micro-ultrasound, and others. Among the products near infrared spectroscopy is anticipated to be the fastest-growing sub-segment.

By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The Asia-Pacific area is predicted to develop at a healthy rate in the next years. Emerging economies such as Japan, China, South Korea, and India are likely to grow considerably throughout the forecast period. The presence of several indigenous businesses in China and Japan may aid the industry's growth. Furthermore, in the next years, the local market will most certainly be pushed by the expanding senior population and the rising occurrence of traumatic brain injuries. According to projections from the national 2020 census, China's elderly population will exceed 300 million by 2025, and 400 million by 2033.

The key players profiled in this report include GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated., Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.

The report focuses on the global neuromonitoring devices market size and the major products & applications, where neuromonitoring devices are used. It further highlights numerous factors that influence the market growth, such as forecast, trends, drivers, restraints, opportunities, and roles of different key players that shape the market. The report focuses on the overall demand for Neuromonitoring devices in various countries, presenting data in terms of both value and volume. The revenue is calculated by proliferating the volume by region-specific prices, considering the region-wise differentiated prices.

IMPACT OF COVID-19 ON THE GLOBAL NEUROMONITORING DEVICES MARKET

  • COVID-19 pandemic had a negative impact on the market of neuromonitoring devices. The demand for neuromonitoring devices reduced due to decreased patients’ hospital visits and admissions amid high prevalence of corona virus infection.
  • Due to the high transmission of the viral infection and severe complications associated with the infection, healthcare professionals were forced to postpone many neurosurgeries, negatively impacting demand for neuromonitoring devices.

Key Findings of the Study

  • On the basis of product, the doppler ultrasound segment emerged as the global leader in 2021 and is anticipated to be the largest market during the forecast period.
  • On the basis of region, Asia-Pacific is projected to have the fastest growing market during the forecast period.
  • The report showcases the indepth analysis of neuromonitoring devices market trends.

Companies Mentioned

  • Koninklijke Philips N.V.
  • Nihon Kohden Corporation
  • Natus Medical Incorporated
  • Medtronic plc
  • Ge Healthcare
  • Nuvasive, Inc.
  • Advanced Brain Monitoring, Inc.
  • Intranerve Neuroscience Holdings, LLC
  • Rimed Ltd.
  • Specialtycare

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...